MedPath

Proprioceptive Neuromuscular Facilitation Protocol for adults with Traumatic Upper Plexus Injury

Not Applicable
Recruiting
Conditions
Traumatic Brachial Plexus Injury
S14.3
Registration Number
RBR-3yc3bg
Lead Sponsor
niversidade Federal de Pernambuco
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Individuals who suffered traumatic upper brachial plexus injury; both sexes; age between 18 and 40 years; clinical diagnosis according to the routine protocol established at the service and confirmed by electrodiagnostic assessment - Electromyography (EMG) and/or Magnetic Resonance Imaging; who have indication of performing nerve transfer surgery; accompanied in the neurosurgery of peripheral nerves ambulatory at the Hospital da Restauração; with the minimum degree of comprehension necessary to understand the questions of the questionnaires, according to the Mini Mental State Examination (MMSE).

Exclusion Criteria

Patients with some type of articular ankylosis (shoulder, elbow, wrist); with incapacitating and uncontrolled neuropathic pain; who have suffered multi-trauma that makes it impossible to perform the positions and exercises of the protocol.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improved functionality, evaluated by the DASH score reduction in the initial, pre-surgical and postoperative evaluation (15 days, 3, 6, 9 and 12 months after).;Perception of patient improvement, assessed by the score obtained from the Patient Global Impression of Change Scale, portuguese version (PGIC - VP), at the end of the intervention.;Improved quality of life, assessed by WHOQOL-BREF brazilian version developed by World Health Organization.
Secondary Outcome Measures
NameTimeMethod
Increased range of joint and shoulder motion, assessed by goniometry, data collected in the initial evaluation, preoperative and postoperative (15 days, 3, 6, 9 and 12 months after).;Increased muscle strength of the shoulder and elbow muscles, assessed by the Medical Research Council Manual Test, data collected in the initial evaluation, preoperative and postoperative (15 days, 3, 6, 9 and 12 months after).;Reduction of pain intensity, evaluated by the numerical scale of pain (0 to 10), and absence of neuropathic pain, evaluated by neuropathic pain questionnaire in 4 questions. Data collected in the initial evaluation, preoperative and postoperative (15 days, 3, 6, 9 and 12 months after).;Sensitivity improvement, classified as normal, by evaluation in the areas of the corresponding C5 and C6 dermatomes, data collected in the initial evaluation, preoperative and postoperative (15 days, 3, 6, 9 and 12 months after).
© Copyright 2025. All Rights Reserved by MedPath